The crucial role of caspase‐9 in the disease progression of a transgenic ALS mouse model

No abstract is available for this paper.

• Publication year

  2003

• Venue

  EMBO Journal

• Publication date

  2003-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/emboj/cdg634PMID 14657037PMCID PMC291829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor neuron diseases

  2005cited by this paper
• Familial Amyotrophic Lateral Sclerosis Mutants of Copper/Zinc Superoxide Dismutase Are Susceptible to Disulfide Reduction*

  2003cited by this paper
• Neurological diseases: Targeting programmed cell death in neurodegenerative diseases

  2003cited by this paper
• Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice.

  2003cited by this paper
• Apoptosis and caspases in neurodegenerative diseases.

  2003cited by this paper
• Programmed cell death in amyotrophic lateral sclerosis.

  2003cited by this paper
• Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease

  2002cited by this paper
• Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis* 210

  2002cited by this paper
• Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

  2002cited by this paper
• Inhibitor specificity of recombinant and endogenous caspase-9.

  2002cited by this paper
• X‐Linked inhibitor of apoptosis protein is involved in mutant SOD1‐mediated neuronal degeneration

  2002cited by this paper
• Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading

  2002cited by this paper
• Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

  2002cited by this paper
• Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

  2002cited by this paper
• Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS.

  2002cited by this paper
• In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons.

  2002cited by this paper
• Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment

  2001cited by this paper
• Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in Amyotrophic Lateral Sclerosis

  2001cited by this paper
• From charcot to lou gehrig: deciphering selective motor neuron death in als

  2001cited by this paper
• A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

  2001cited by this paper
• Specific Caspase Pathways Are Activated in the Two Stages of Cerebral Infarction

  2001cited by this paper
• Cardiotrophin-1, a Muscle-Derived Cytokine, Is Required for the Survival of Subpopulations of Developing Motoneurons

  2001cited by this paper
• Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death

  2001cited by this paper
• Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.

  2001cited by this paper
• IAP family proteins delay motoneuron cell death in vivo

  2000cited by this paper
• Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Neurobiology. Stay the executioner's hand.

  2000cited by this paper
• An alternative, nonapoptotic form of programmed cell death.

  2000cited by this paper
• Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.

  2000cited by this paper
• Stay the Executioner's Hand

  2000cited by this paper
• Amyotrophic lateral sclerosis: pathogenesis.

  2000cited by this paper
• Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune‐mediated demyelination

  2000cited by this paper
• Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration.

  2000cited by this paper
• Apoptosis in the nervous system

  2000cited by this paper
• The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo

  2000cited by this paper
• IAP family proteins--suppressors of apoptosis.

  1999cited by this paper
• Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

  1999cited by this paper
• Identification and Transgenic Analysis of a Murine Promoter that Targets Cholinergic Neuron Expression

  1999cited by this paper
• Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation.

  1999cited by this paper
• Caspase inhibitors

  1999cited by this paper
• Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.

  1999cited by this paper
• Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.

  1998cited by this paper
• Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase.

  1998cited by this paper
• Detection of activated Caspase-3 by a cleavage site-directed antiserum during naturally occurring DRG neurons apoptosis.

  1998cited by this paper
• Inhibition of ICE slows ALS in mice

  1997cited by this paper
• Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis.

  1997cited by this paper
• A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.

  1997cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• The biological responses of axotomized adult motoneurons to brain- derived neurotrophic factor

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• ATLAS OF THE MOUSE BRAIN AND SPINAL CORD

  1972cited by this paper
• Diseases of the Nervous System

  1892cited by this paper

• Brain-derived exosomes from aged mice accelerate cognitive decline in repeated mild traumatic brain injury by activating neuronal Tnfrsf25.

  2025cites this paper
• Swimming and L-arginine loaded chitosan nanoparticles ameliorates aging‐induced neuron atrophy, autophagy marker LC3, GABA and BDNF-TrkB pathway in the spinal cord of rats

  2023cites this paper
• Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1G93A Mice Models Uncover Potential Drug Treatments for ALS

  2022cites this paper
• Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia

  2022cites this paper
• Autologous treatment for ALS with implication for broad neuroprotection

  2022cites this paper
• The Novel Regulatory Role of lncRNA-miRNA-mRNA Axis in Amyotrophic Lateral Sclerosis: An Integrated Bioinformatics Analysis

  2021cites this paper
• Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease

  2021cites this paper
• Caspase Signaling Pathways as Convenors of Stress Adaptation

  2021cites this paper
• A long way to go: caspase inhibitors in clinical use

  2021influential citation
• Excitotoxicity and genetics of amyotrophic lateral sclerosis: effects of intracellular calcium accumulation on proteins encoded by the major genes underlying the disease

  2021cites this paper
• Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells

  2020cites this paper
• Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo

  2019cites this paper
• Apoptotic cell death regulation in neurons

  2019cites this paper
• A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1G93A Rats

  2019cites this paper
• Leserbrief

  2018cites this paper
• Caspase-9 CARD : core domain interactions require a properly formed active site.

  2018cites this paper
• The Bcl-2 Homology-3 Domain (BH3)-Only Proteins, Bid, DP5/Hrk, and BNip3L, Are Upregulated in Reactive Astrocytes of End-Stage Mutant SOD1 Mouse Spinal Cord

  2018cites this paper
• The Molecular Basis of Caspase-9 Inactivation by PKA and c-Abl Kinases

  2018cites this paper
• Gene Therapy for Amyotrophic Lateral Sclerosis

  2017cites this paper
• Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs

  2017cites this paper
• Endothelial Caspase-9 Activity Exacerbates Edema and Neuronal Dysfunction after Retinal Vein Occlusion

  2017cites this paper
• Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant

  2017cites this paper
• cIAPs promote the proteasomal degradation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.

  2016cites this paper
• Activated caspase-9 immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.

  2016cites this paper
• Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases

  2016cites this paper
• New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway

  2016cites this paper
• The role of ALS associated genes and c-Jun in neurodegeneration

  2016cites this paper
• Endoplasmic reticulum stress and proteasomal system in amyotrophic lateral sclerosis.

  2015cites this paper
• Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases

  2015cites this paper
• Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles

  2015cites this paper
• Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis

  2015cites this paper
• Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration

  2015cites this paper
• Microglia centered pathogenesis in ALS: insights in cell interconnectivity

  2014cites this paper
• Whole Genome Sequence of a Turkish Individual

  2014cites this paper
• Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration

  2014cites this paper
• Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.

  2014cites this paper
• XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.

  2014cites this paper
• Dysfonctions mitochondriales et homéostasie bioénergétique des motoneurones dans un modèle de sclérose latérale amyotrophique

  2013cites this paper
• Neuroprotective Role of the Basic Leucine Zipper Transcription Factor NFIL3 in Models of Amyotrophic Lateral Sclerosis*

  2013cites this paper
• Multiple Routes of Motor Neuron Degeneration in ALS

  2013cites this paper
• An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies

  2012cites this paper
• c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral Sclerosis

  2012cites this paper
• An attempt to treat amyotrophic lateral sclerosis by intracellular copper modification using ammonium tetrathiomolybdate and/or metallothionein: Fundamentals and perspective

  2012cites this paper
• Regulation of Caspase-9 by Natural and Synthetic Inhibitors

  2012cites this paper
• Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis

  2012cites this paper
• INVESTIGATION OF THE CYTOPROTECTIVE EFFECTS OF SONIC HEDGEHOG IN CELLULAR AND ANIMAL MODELS OF AMYOTROPHIC LATERAL SCLEROSIS

  2012cites this paper
• Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases.

  2011cites this paper
• Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies

  2011cites this paper
• Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis

  2011cites this paper
• TDP-43-induced Death Is Associated with Altered Regulation of BIM and Bcl-xL and Attenuated by Caspase-mediated TDP-43 Cleavage*

  2011cites this paper
• Current nervous system related drug targets for the treatment of amyotrophic lateral sclerosis.

  2010cites this paper
• Clinical trials for neuroprotection in ALS.

  2010cites this paper
• Physiological and Pathological Role of Apoptosis

  2010cites this paper
• Suppression of the Intrinsic Apoptosis Pathway by Synaptic Activity

  2010cites this paper
• Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.

  2010cites this paper
• HtrA2/Omi‐immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis

  2010cites this paper
• Role of Pro-Apoptotic BCL2-homology-3 Domain (BH3)-only Proteins in the Mutant SOD1 Mouse Model of ALS

  2009cites this paper
• Protein Misfolding and Axonal Protection in Neurodegenerative Diseases

  2009cites this paper
• Caspase-9 Activation Revealed by Semaphorin 7A Cleavage Is Independent of Apoptosis in the Aged Olfactory Bulb

  2009cites this paper
• The mechanism of Cu,Zn superoxide dismutase oligomerization in familial amyotrophic lateral sclerosis

  2009cites this paper
• Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

  2009cites this paper
• Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis

  2008cites this paper
• Morphological Aspects of Neuronal Dysfunction Caused by Protein Aggregation / Misfolding in Human Neurodegenerative Disorder

  2008cites this paper
• Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

  2008influential citation
• Inhibitory Effect of PACAP on Caspase Activity in Neuronal Apoptosis: A Better Understanding Towards Therapeutic Applications in Neurodegenerative Diseases

  2008cites this paper
• Cell Death in Brain Development and Degeneration: Control of Caspase Expression May Be Key!

  2008cites this paper
• ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.

  2008cites this paper
• A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies.

  2008cites this paper
• [Neuronal death in amyotrofic lateral sclerosis].

  2008cites this paper
• Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.

  2008cites this paper
• A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies

  2008cites this paper
• Novel interactors of X-linked inhibitor of apoptosis protein : expression and effects on tumor cell death.

  2008cites this paper
• Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.

  2007cites this paper
• Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.

  2007cites this paper
• Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling.

  2007cites this paper
• Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.

  2007cites this paper
• Role of zinc in ALS

  2007cites this paper
• Minocycline for amyotrophic lateral sclerosis or motor neuron disease

  2007cites this paper
• Concurrent Administration of Neu 2000 and Lithium Produces Marked Improvement of Motor Neuron Survival , Motor Function , and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis

  2007cites this paper
• Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.

  2007cites this paper
• Intrathecal Delivery of Hepatocyte Growth Factor From Amyotrophic Lateral Sclerosis Onset Suppresses Disease Progression in Rat Amyotrophic Lateral Sclerosis Model

  2007cites this paper
• Mitochondrial involvement in amyotrophic lateral sclerosis

  2007cites this paper
• Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis

  2007cites this paper
• Motor Neuron Disease

  2006cites this paper
• The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy.

  2006cites this paper
• The role of mitochondria in inherited neurodegenerative diseases

  2006cites this paper
• Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment

  2006cites this paper
• Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis.

  2006cites this paper
• XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice.

  2006cites this paper
• XIAP GENE‐BASED NEUROPROTECTIONFOR THE PERIPHERAL NERVOUS SYSTEM

  2006cites this paper
• Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.

  2006cites this paper
• Neuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders

  2006cites this paper
• Strategies to prevent motoneuron degeneration in models of Amyotrophic Lateral Sclerosis.

  2006cites this paper
• ER stress and neurodegenerative diseases

  2006cites this paper
• Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

  2006cites this paper
• X-Linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system.

  2006cites this paper
• Disease progression of human SOD1 (G93A) transgenic ALS model rats

  2006cites this paper